SCHEMBL4189874

SCHEMBL4189874

CC(CC1CC1)NCc1ccccc1NC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 2/20 0.41
CCR3 P51677 3/20 0.40
TDP1 Q9NUW8 1/20 0.38
MAPK1 P28482 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4192548 0.94 KMT2A (0.47) KDM4EL3MBTL1KMT2AALDH1A1POLB
SCHEMBL4199680 0.92 CHRM3 (0.41) KDM4EL3MBTL1KMT2AALDH1A1POLB
SCHEMBL4196799 0.82 CCR3 (0.50) KDM4EKMT2AALDH1A1CCR3MEN1
SCHEMBL4196629 0.82 KMT2A (0.48) L3MBTL1KMT2AALDH1A1POLBCCR3
SCHEMBL4197445 0.82 KMT2A (0.48) L3MBTL1KMT2AALDH1A1POLBCCR3
SCHEMBL4195095 0.82 KMT2A (0.48) L3MBTL1KMT2AALDH1A1POLBCCR3
SCHEMBL4199684 0.81 ALDH1A1 (0.48) KDM4EKMT2AALDH1A1POLBMEN1
SCHEMBL4199681 0.81 ALDH1A1 (0.48) KDM4EKMT2AALDH1A1POLBMEN1
SCHEMBL4194018 0.80 IDO1 (0.46) KMT2AALDH1A1SMN1; SMN2
SCHEMBL4197653 0.80 CTSL (0.45) KMT2ACCR3MEN1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885L3MBTL1 2192/4885KMT2A 2047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.